Superior neovascularization and muscle regeneration in ischemic skeletal muscles following VEGF gene transfer by rAAV1 pseudotyped vectors

This publication has 44 references indexed in Scilit:

• Gene Therapy Progress and Prospects: Recombinant adeno-associated virus (rAAV) vectors
  Gene Therapy, 2004
• Efficient and long-term intracardiac gene transfer in δ-sarcoglycan-deficiency hamster by adeno-associated virus-2 vectors
  Gene Therapy, 2003
• Phase I Trial of Intranasal and Endobronchial Administration of a Recombinant Adeno-Associated Virus Serotype 2 (rAAV2)-CFTR Vector in Adult Cystic Fibrosis Patients: A Two-Part Clinical Study
  Human Gene Therapy, 2003
• AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B
  Blood, 2003
• A Phase II, Double-Blind, Randomized, Placebo-Controlled Clinical Trial of tgAAVCF Using Maxillary Sinus Delivery in Patients with Cystic Fibrosis with Antrostomies
  Human Gene Therapy, 2002
• Adeno-associated virus effectively mediates conditional gene modification in the brain
  Proceedings of the National Academy of Sciences, 2002
• A Phase I Study of Aerosolized Administration of tgAAVCF to Cystic Fibrosis Subjects with Mild Lung Disease
  Human Gene Therapy, 2001
• Improvement of erythropoiesis in β-thalassemic mice by continuous erythropoietin delivery from muscle
  Blood, 2000
• Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
  Nature Genetics, 2000
• Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors
  Nature Genetics, 1997